Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Enzymotec Appoints Steve Dubin As Chairman

Enzymotec Ltd. (ENZY: Quote), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced Thursday that it has appointed Steve Dubin as Chairman of its board of directors, effective January 1, 2014.

The company also announced that it has appointed Yoav Doppelt as Vice Chairman of the board. Doppelt has served as Chairman of Enzymotec's board of directors since October 2011 and as a director since 2001. He will continue to be an actively involved board member and will assist Dubin during the transition process.

Steve Dubin has served as Vice Chairman of Enzymotec's board of directors since April 2013. Since November 2011, Dubin has been a Principal in SDA Ventures LLC.

Dubin also acts as a Senior Advisor to Paine & Partners, LLC. From 2006 until its acquisition by Royal DSM N.V. in February 2011, Dubin served as Chief Executive Officer and a member of the board of directors of Martek Biosciences Corporation. He also served as President of DSM's Nutritional Lipids Division immediately after DSM's acquisition of Martek and as a Senior Advisor to DSM Nutritional Products from 2011 through October 2012.

Having joined Martek in 1992, he held various management positions, including Chief Financial Officer, Treasurer, Secretary, General Counsel and Senior Vice President, Business Development, as well as President of Martek from 2003 to 2006.

Dubin is a co-founder and co-manager of a Maryland-based, angel-investing club. Dubin currently serves as a member of the board of several privately held companies, including The Brain Center, LLC, MyCell Technologies and its subsidiary Oceans Omega LLC, and Alcresta, Inc. Prior to that, he was a member of the board of directors of Scerene Healthcare Inc.

Register
To receive FREE breaking news email alerts for Enzymotec Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.